Patent · US Active

Crystalline forms of cadazolid

US10087171B2 · kind B2 · utility

0Cited by

6References

16Claims

0Family size

Inventors

Christian Hubschwerlen · Durmenach, FR
Philippe Panchaud · Allschwil, CH
Timo Rager · Mainz, DE
Jean-Luc Specklin · Sarrebourg, FR

Key dates

Filing date	Dec 18, 2017
Grant date	Oct 2, 2018
Priority date	—
Expiry date	Dec 18, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to crystalline forms of cadazolid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.